Evidence map›Paper›PMID 41488695›Full record

ArticleOpen forum infectious diseases2026

Analysis of Tuberculosis Preventive Treatment Cascade Among People With Human Immunodeficiency Virus in Georgia: A Mixed-Methods Study.

Mariana Buziashvili, Davit Baliashvili, Akaki Abutidze, Nikoloz Chkhartishvili, Nestani Tukvadze, Otar Chokoshvili, Jack DeHovitz, Mamuka Djibuti

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mariana BuziashviliScientific Research Unit, National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia.ORCID https://orcid.org/0000-0001-8434-1811
Davit BaliashviliPartnership for Research and Action for Health, Tbilisi, Georgia.ORCID https://orcid.org/0000-0001-8390-3325
Akaki AbutidzeT. Tsertsvadze Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia.
Nikoloz ChkhartishviliT. Tsertsvadze Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia.ORCID https://orcid.org/0000-0002-1309-825X
Nestani TukvadzeScientific Research Unit, National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia.ORCID https://orcid.org/0000-0002-0276-1204
Otar ChokoshviliT. Tsertsvadze Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia.ORCID https://orcid.org/0000-0003-3023-1902
Jack DeHovitzDepartment of Medicine, State University of New York Downstate Health Sciences University, Brooklyn, New York, USA.ORCID https://orcid.org/0000-0001-7307-0614
Mamuka DjibutiPartnership for Research and Action for Health, Tbilisi, Georgia.ORCID https://orcid.org/0000-0002-1614-854X

Funding

Emory/Georgia TB Research Advancement Center (TRAC)P30AI168386 · NIAID · EMORY UNIVERSITY · PI Jeffrey M Collins · 2022 to 2026
$5.8M
Emory-Georgia TB Research Training ProgramD43TW007124 · FIC · EMORY UNIVERSITY · PI HENRY M BLUMBERG, Nestani Tukvadze · 2004 to 2026
$4.6M
Vascular contributions to cognitive impairments and dementia (VCID) among people living with HIV in the country of GeorgiaD43TW011532 · FIC · PARTNERSHIP FOR RESEARCH/ACTION/HEALTH · PI DEHOVITZ, JACK A, DJIBUTI, MAMUKA · 2020 to 2024
$1.8M
FIC NIH HHS D43 TW007124FIC NIH HHS D43 TW011532NIAID NIH HHS P30 AI168386
6 · The paper itself

Abstract

Background: Tuberculosis preventive treatment (TPT) is crucial for reducing tuberculosis (TB) incidence and related mortality among people with human immunodeficiency virus (HIV); however, its implementation in Georgia faces challenges. In this study, we aimed to explore the TPT care cascade among people with HIV (PWH) in Georgia. Methods: Using a mixed-methods approach, we assessed TPT uptake, adherence, and impact on TB development within the 2019-2020 cohort of newly diagnosed PWH across 4 major HIV service providers in Georgia. With qualitative analysis under the Consolidated Framework for Implementation Research, we identified barriers and facilitators to its implementation. Results: Among 1165 PWH, only 11.8% initiated TPT with isoniazid. Thirty-two developed active TB (incidence rate, 10/1000 person-years [95% confidence interval, 9.6-10.4]), none of whom received TPT. Only 43% of 137 PWH on TPT adhered for 3-6 months; 29 (21.1%) completed the full course. The study revealed poor TPT service coordination, worsened by major data limitations. Interviews identified several barriers to effective TPT implementation, summarized into 3 broad categories: the need for TPT service integration into HIV care, the potential development of an integrated electronic data system, and training gaps. Conclusions: Our study revealed low TPT coverage among Georgian PWH and significant data gaps. Findings underscore the need to reevaluate the TPT care cascade, emphasizing improved record-keeping and reporting practices through an integrated electronic system. Enhancing access by integrating TPT into HIV care, reducing stigma through streamlined referrals, and strengthening healthcare worker training are critical to increasing TPT uptake and ultimately reducing TB morbidity and mortality among PWH in Georgia.

Indexed as

barriers and facilitators to TPT implementationcare cascadeHIVpeople with HIVtuberculosis preventive treatment

Identifiers

PMID41488695
PMCPMC12757687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.